What does this Instagram post actually claim?
@deluciavitality promotes "science-backed treatments" for weight loss that help clients "feel sexier, healthier" through personalized support. The post uses transformation photos and promises sustainable results using what appears to be peptide therapy based on the hashtags.
The practitioner, who identifies as an MSN, APRN, FNP-C, positions herself as offering "VIP injector experience" and functional medicine approaches. She's targeting people wanting weight loss through what she calls evidence-based treatments.
Are peptides actually "science-backed" for weight loss?
Most peptides marketed for weight loss lack strong clinical evidence. Unlike FDA-approved GLP-1 medications like semaglutide, which showed 14.9% weight loss in the STEP 1 trial (Wilding et al., NEJM, 2021), common peptides like CJC-1295 and ipamorelin don't have large randomized controlled trials proving weight loss efficacy.
BPC-157, often promoted for healing, has only been studied in animal models. TB-500 research is similarly limited to preclinical studies. The FDA has specifically warned against using many of these peptides outside of approved research contexts.
GHK-Cu has some evidence for wound healing in small studies, but not for weight management. The gap between marketing claims and actual evidence is significant.
What's misleading about this approach?
Calling peptide therapy "science-backed" overstates the current evidence. While some peptides show promise in early research, most lack the rigorous human trials required to prove safety and efficacy for weight loss.
The transformation photos, while compelling, don't constitute clinical evidence. Individual results can't be generalized without controlled studies accounting for diet, exercise, and other variables.
Positioning these treatments as equivalent to proven therapies misleads patients about what level of evidence actually supports their use.
What should people actually know about peptide therapy?
Most peptides marketed for weight loss operate in a regulatory gray area. They're not FDA-approved medications, and many are sold as research chemicals not intended for human consumption.
If you're considering weight management, start with proven approaches. Semaglutide at 2.4mg showed consistent results across multiple trials. Liraglutide achieved 8.4% weight loss in the SCALE trial (Pi-Sunyer et al., NEJM, 2015).
Work with providers who can clearly explain the evidence level for any treatment they recommend. Ask specifically about FDA approval status and published human trials.